Table 1.
Baseline descriptive characteristics for Women’s Healthy Eating and Living Study participants by race.
| Variable | Asian American | African American | Hispanic | white | P value† |
|---|---|---|---|---|---|
| n = 96 | n = 118 | n = 165 | n = 2634 | ||
| Median age at randomization, (25%, 75%) | 52 (47, 58) | 49 (43, 54) | 50 (44, 57) | 52 (47, 59) | <0.001 |
| Median time from diagnosis, (25%, 75%) | 2 (1, 3) | 2 (1, 3) | 2 (1, 2) | 2 (1, 3) | 0.216 |
| Median age at diagnosis, (25%, 75%) | 50 (45, 56) | 47 (42, 52) | 48 (42, 55) | 51 (45, 57) | <0.001 |
| Median body mass index, (25%, 75%) | 24.4 (22, 28) | 29.3 (26, 34) | 26.9 (24, 31) | 25.7 (23, 30) | <0.001 |
| Stage of diagnosis, n (%) | 0.308 | ||||
| I | 41 (43) | 38 (32) | 51 (31) | 1034 (39) | |
| IIA | 28 (29) | 44 (37) | 71 (43) | 861 (33) | |
| IIB | 12 (13) | 18 (15) | 15 (9) | 322 (12) | |
| IIIA | 12 (13) | 15 (13) | 20 (12) | 319 (12) | |
| IIIC | 3 (3) | 3 (3) | 8 (5) | 98 (4) | |
| Treatment, n (%) | |||||
| Mastectomy/Lumpectomy | 55 (57) | 59 (50) | 87 (53) | 1366 (52) | 0.725 |
| Radiation | 56 (59) | 79 (67) | 103 (62) | 1622 (62) | 0.639 |
| Adjuvant chemotherapy | 73 (76) | 91 (77) | 129 (78) | 1814 (69) | 0.010 |
| Anti-estrogen therapy | 75 (78) | 68 (56) | 108 (65) | 1807 (69) | 0.011 |
| % Premenopausal | 9 (9) | 22 (19) | 25 (15) | 286 (11) | 0.020 |
Note: All data are no. of patients (%) unless otherwise indicated.
†
Compares descriptive characteristics between racial groups. Continuous P-values are base on nonparametric Kruskall Wallis test, whereas categorical P-values are based on chi-square test for independence.